Comparison results
| Results: Differences General | ✘Ischemic neuropathy of the optic nerve | ✘Subclavian theft syndrome | |||||||
| Related research | Analogs | Analogs | |||||||
| |||||||||
| Distinctive symptoms | |||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | |||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
| increased | 99% | — | |||||||
| subclavian theft syndrome | — | 93% | |||||||
| angiopathy | 92% | — | |||||||
| cervical migraine | — | 49% | |||||||
| leukocytosis | 85% | — | |||||||
| arterial occlusion | — | 48% | |||||||
| wedge-shaped defect | 83% | — | |||||||
| takayasu's disease | — | 44% | |||||||
| anemia | 80% | — | |||||||
| stair muscle syndrome | — | 43% | |||||||
| scotoma | 79% | — | |||||||
| congenital syphilis | — | 42% | |||||||
| loss of visual fields | 74% | — | |||||||
| neck ribs | — | 42% | |||||||
| absolute neutrophilia | 66% | — | |||||||
| obliterating atherosclerosis | — | 36% | |||||||
| giant cell arteritis | 63% | — | |||||||
| consequences of stroke | — | 36% | |||||||
| horton's disease | 58% | — | |||||||
| pre-fainting condition | — | 34% | |||||||
| neurological disorders | 56% | — | |||||||
| transient ischemic attack | — | 34% | |||||||
| acute coronary syndrome | 56% | — | |||||||
| weakness in the extremities | — | 32% | |||||||
| pale optic discs | 54% | — | |||||||
| ataxia | — | 30% | |||||||
| CHD | 53% | — | |||||||
| syphilis | — | 30% | |||||||
| ocular ischemic syndrome | 52% | — | |||||||
| stroke | — | 28% | |||||||
| angina pectoris | 51% | — | |||||||
| impaired coordination | — | 28% | |||||||
| blindness | 51% | — | |||||||
| dizziness | — | 27% | |||||||
| sharpness decreased vision | 51% | — | |||||||
| muscle weakness | — | 26% | |||||||
| heart dysfunction | 48% | — | |||||||
| imbalance | — | 25% | |||||||
| increased pressure under stress | 45% | — | |||||||
| weakness after illness | — | 25% | |||||||
| acute condition | 45% | — | |||||||
| angioplasty | — | 23% | |||||||
| neurological pain | 43% | — | |||||||
| lowered | — | 22% | |||||||
| rheumatic polymyalgia | 43% | — | |||||||
| impaired arterial function | 33% | 41% | |||||||
| rheumatic muscle pain | 42% | — | |||||||
| hemianopsia | 39% | 39% | |||||||
| transient blindness | 42% | — | |||||||
| soft tissue rheumatism | 41% | — | |||||||
| atheroma | 41% | — | |||||||
| atherosclerosis of the carotid arteries | 40% | — | |||||||
| trypanosomiasis | 40% | — | |||||||
| pain in the eyes | 40% | — | |||||||
| essential hypertension | 39% | — | |||||||
| common arterial trunk | 37% | — | |||||||
| changes in the blood | 37% | — | |||||||
| ischemic neuropathy of the optic nerve | 37% | — | |||||||
| headaches | 36% | — | |||||||
| periodic headaches | 36% | — | |||||||
| systemic vasculitis | 36% | — | |||||||
| hypertension | 35% | — | |||||||
| up circulatory disorders | 35% | — | |||||||
| headache behind the eyes | 35% | — | |||||||
| atherosclerosis of the aorta | 35% | — | |||||||
| rheumatic inflammation | 35% | — | |||||||
| blurred vision | 66% | 29% | |||||||
| optic nerve atrophy | 34% | — | |||||||
| swelling | 34% | — | |||||||
| He's been ill for a long time | 34% | — | |||||||
| rheumatism | 33% | — | |||||||
| visual impairment | 61% | 27% | |||||||
| angiopathy of the retina | 32% | — | |||||||
| arterial bleeding | 31% | — | |||||||
| hypotension | 30% | — | |||||||
| clear boundaries | 30% | — | |||||||
| painful appearance | 29% | — | |||||||
| up vascular mesh | 29% | — | |||||||
| illness from stress | 29% | — | |||||||
| muscle pain | 28% | — | |||||||
| stress | 26% | — | |||||||
| thrombosis | 26% | — | |||||||
| diabetes mellitus | 26% | — | |||||||
| hypotension | 26% | — | |||||||
| bleeding | 25% | — | |||||||
| impaired venous function | 25% | — | |||||||
| patient's condition | 22% | — | |||||||
| vasculitis | 45% | 31% | |||||||
| atherosclerosis of blood vessels | 41% | 29% | |||||||
| inflammation | 31% | 22% | |||||||
| blood diseases | 32% | 23% | |||||||
Instructions
Video
|